Skip to main content

CAP TODAY/ Agilent Webinar: PD-L1 IHC 22C3 pharmDx in TNBC: from KEYNOTE-355 to real-world scoring

Thank you

This live web event has ended. Thank you for attending.

Description



PD-L1 IHC 22C3 pharmDx
in TNBC:
 from KEYNOTE-355
to real-world scoring


Why should you register now for this webinar?
Understand the practical use of PD-L1 IHC 22C3 pharmDx in TNBC, and get tips
for high-quality implementation in your lab.
Brought to you by: CAP TODAY
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Presenters: Corrado D’Arrigo, MD, and Teresa Thomas, MD

What will this webinar empower you to do?

  • Understand how to apply the clinically-validated Combined Positive Score (CPS) in PD-L1 testing for TNBC
  • Explore how to score real TNBC cases
  • Discuss the differences between PD-L1 assays approved for TNBC
  • Ask questions of our distinguished presenters

CAP TODAY does not endorse any of the products or services named within.
The webinar is made possible by a special educational grant from Agilent Technologies.

Contributors

  • Corrado D’Arrigo, MD

    Poundbury Cancer Institute for
    Personalized Medicine, UK

  • Teresa Thomas, MD

    Poundbury Cancer Institute for
    Personalized Medicine, UK

  • Bob McGonnagle

    Publisher, CAP TODAY

May 19, 2021
Wed 1:00 PM EDT

Duration 1H 0M

This live web event has ended.

For Technical Support
+1 (858) 201-4136